Gevorg Grigoryan, PhD, is co-founder & Chief Technology Officer at Generate:Biomedicines, where he leads development of the Generate Platform—an integrated system for generating new drugs on demand across diverse biologic modalities.

Gevorg is a cross-disciplinary thinker whose scientific contributions span computer science, biophysics, and molecular biology. His research at Dartmouth College—where he held faculty appointments in computer science, biological sciences, and chemistry—focused on uncovering the principles that link protein sequence, structure, and function. This work led to foundational advances in data-driven protein modeling and design, ultimately laying the scientific groundwork for Generate.

Motivated by the belief that therapeutic discovery could be reimagined through machine learning and programmable biology, Gevorg co-founded Generate in partnership with Flagship Pioneering. The company embodies his conviction that the future of medicine lies in systematically generating, rather than searching for, new drugs.

He holds bachelor’s degrees in computer science and biochemistry, a PhD from the Massachusetts Institute of Technology, and completed postdoctoral training at the University of Pennsylvania. Gevorg received tenure at Dartmouth in 2017.

He has authored over 50 peer-reviewed publications in leading journals, including Nature, Science, and PNAS, and has received recognition from the Alfred P. Sloan Foundation, NIH, NSF, and the American Cancer Society.